VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 94 filers reported holding VERONA PHARMA PLC in Q1 2023. The put-call ratio across all filers is 1.24 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,206,901 | -29.5% | 74,043 | -8.5% | 0.00% | – |
| Q2 2023 | $1,710,818 | -58.6% | 80,928 | -60.7% | 0.00% | – |
| Q1 2023 | $4,134,391 | -7.5% | 205,896 | +20.3% | 0.00% | -100.0% |
| Q4 2022 | $4,471,314 | +8667.3% | 171,118 | +3337.5% | 0.00% | – |
| Q3 2022 | $51,000 | +24.4% | 4,978 | -49.1% | 0.00% | – |
| Q2 2022 | $41,000 | -12.8% | 9,785 | +3.5% | 0.00% | – |
| Q1 2022 | $47,000 | -2.1% | 9,453 | +30.1% | 0.00% | – |
| Q4 2021 | $48,000 | +6.7% | 7,268 | -11.3% | 0.00% | – |
| Q3 2021 | $45,000 | +87.5% | 8,194 | +123.0% | 0.00% | – |
| Q2 2021 | $24,000 | +84.6% | 3,674 | +144.9% | 0.00% | – |
| Q1 2021 | $13,000 | +8.3% | 1,500 | -7.9% | 0.00% | – |
| Q4 2020 | $12,000 | +33.3% | 1,628 | +8.5% | 0.00% | – |
| Q3 2020 | $9,000 | – | 1,500 | +149900.0% | 0.00% | – |
| Q1 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 1 | -99.5% | 0.00% | – |
| Q1 2018 | $4,000 | – | 201 | +1240.0% | 0.00% | – |
| Q4 2017 | $0 | – | 15 | +7.1% | 0.00% | – |
| Q3 2017 | $0 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
| Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
| Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
| Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
| NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
| Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
| Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
| RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
| Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |